Plasma homocysteine concentration and coronary artery disease in Asian Indians

Journal of Association of Physicians of India

Volumn 50, Issue 10, 2002, Pages 1229-1231

  Snehalatha, C ^a   Ramachandran, A ^a   Satyavani, K ^a   Sivasankari, S ^a   Sathyamurthy, I ^b   Viswanathan, V ^a  

^a Diabetes Research Centre Tamil Nadu   (India)

^b APOLLO HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; ENZYMOLOGY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOSPITALIZATION; HUMAN; INCIDENCE; INDIA; MALE; METABOLISM; MIDDLE AGED; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036824854     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Balarajan R. Ethnicity and variations in mortality from coronary heart disease. Health Trends 1996;28:45-51.
2. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993;87:152-61.
3. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 1997;40:232-7.
4. Hankey JH, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407-13.
5. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
6. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
7. Perry U, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
8. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7.
9. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA 1997;277:1775-81.
10. Okada E, Oida K, Tada H, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with Type 2 diabetes. Diabetes Care 1999;22:484-90.
11. Chacko KA. Plasma homocysteine levels in patients with coronary heart disease. Indian Heart J 1998;50:295-9.
12. Fallen UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith GD. Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up. Heart 2001;85:153-8.
13. Danesh J, Whincup P, Walker M, et al. Low-grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
14. Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V. Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J 2001;53:44-7.
15. 12 and cardiovascular risk in Indians, Malays and Chinese in Singapore. J Epidemiol Community Health 2000;54:31-4.
16. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-53.